ROIV
Roivant Sciences Ltd. · Healthcare
President and CIO Mayukh Sukhatme sold $34.1M of Roivant Sciences Ltd.
Sold$34,105,000
$34.10Price
1,000,000Shares
−5%Stake
What ROIV did after the filing
- The stock from Tue, Jun 30 open, $34.77
- +4.0%
- S&P 500, same days
- +4.2%
Measured over 30 trading days, to the Aug 12 close.
Traded Thu, Jun 25. Filed Mon, Jun 29, 6:23 PM ET, after the close. Returns use the Jun 30 open and the Aug 12 close. Not investment advice.